10x Genomics, Inc.
NASDAQ10x Genomics heads into mid-June with a striking contrast: short sellers are quietly reducing positions into a 50% monthly price rally, while the options market is turning increasingly bullish — a combination that tells a clear story about the pressure building on the bear side. The short positioning story is the most interesting thing in this data. Short interest has dropped…
Snapshot as of 18 Jun 2026
10x Genomics heads into mid-June with a striking contrast: short sellers are quietly reducing positions into a 50% monthly price rally, while the options market is turning increasingly bullish — a combination that…
10x Genomics reports Q1 2026 results today carrying a notable short position that has been quietly unwinding — and analysts who have spent the past month lifting their targets ahead of the print. Short interest at…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TXG — free to start on ORTEX.
Sign up for free →Open TXG on ORTEX